Meridian Life Science, Inc.
5171 Wilfong Road
About Meridian Life Science, Inc.
Meridian Bioscience is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and biopharmaceutical enabling technologies that help deliver answers. Our products provide accuracy, simplicity and speed for the early diagnosis and treatment of common medical conditions, such as C. difficile, H. pylori., foodborne diseases. and respiratory infections.
For more than 30 years, Meridian Bioscience, Inc., has established a proven track record of profitable growth and product launches designed to enhance patient well being while reducing the total outcome costs of healthcare. Meridian diagnostic products are used outside of the human body and require little or no special equipment.
We maintain market leadership by responding to emerging diseases and changing medical needs. Since 1991, Meridian has developed and introduced more than 56 innovative products. Meridian also grows through acquisition, licensing, or supply agreements that have added almost 100 new products to our catalog.
Meridian has strong market positions in the areas of gastrointestinal infections, serology, parasitology and fungal disease diagnosis. We actively market our products to hospitals, reference laboratories, research centers, physician offices and diagnostics manufacturers in more than 60 countries around the world.
Our shares are traded on the NASDAQ National Market, symbol VIVO.
192 articles with Meridian Life Science, Inc.
Meridian Bioscience, Inc. To Present At The InvesTristate Regional Public Company Investment Conference
Meridian Bioscience, Inc. Helicobacter Pylori Patent Validated By Settlement Agreement With Astra S.r.l.
Meridian Bioscience, Inc. (VIVO) Targets Biodefense Market By Providing Contract Services For BEI Resources